{
  "issued_date": "2013-10-17", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON326446", 
  "doc_details": {
    "Type": "Drug Alert", 
    "Series No": "EL (13)A/24", 
    "Audience": "Healthcare professionals", 
    "Published": "17 October 2013", 
    "Format": "Electronic only", 
    "Size": "A4", 
    "Pages": "2", 
    "Price": "", 
    "ISBN/ISSN": "", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": " Class 2 Medicines Recall (action within 48 Hours): Multiple products - Wockhardt UK Limited (EL (13)A/24) (71Kb)", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/is-md/documents/drugalert/con326447.pdf", 
      "filename": "downloads/19182f7ddb7faef4ffd587fdf0e83b85ed7e36ca/con326447.pdf", 
      "original_filename": "con326447.pdf"
    }
  ], 
  "body": "## DRUG ALERT\n\nCLASS 2 MEDICINES RECALL\n\nAction within 48 hours\n\n  \n\n\nPharmacy, Clinic and Wholesaler Level Recall  \n  \n17 October 2013  |   |  EL (13)A/24  |   |  Our ref:\u00a0 MDR 56-07/13   | \n\n* * *\n\nDear Healthcare Professional,\n\nWockhardt UK Limited\n\nFollowing Drug Alert EL(13)A/19 a second Wockhardt manufacturing site in India has been inspected.\u00a0 The inspection identified deficiencies in good manufacturing practice (GMP) and the GMP certificate for this site has also been withdrawn.\n\nAll unexpired stock of the below products is being recalled to pharmacy, clinic and wholesaler level, for all batches starting with the letter 'L', irrespective of pack configuration and expiry date.  \n  \nAmiloride HCl 5mg Tablets  |   |  PL 29831/0006  |   \nClarithromycin 250mg Tablets  |   |  PL 29831/0476  |   \nClarithromycin 500mg Tablets  |   |  PL 29831/0477  |   \nGliclazide 80mg Tablets  |   |  PL 29831/0103  |   \nQuinine Sulphate 300mg Tablets  |   |  PL 29831/0182  |   \nTamsulosin Pinexel 400mcg Capsules  |   |  PL 29831/0366  | \n\n  \n\n\nThese products have been tested on importation and Qualified Person (QP) released. There is no evidence of a risk to patient safety from products currently in the UK market; however it is considered that the products have not been manufactured in line with GMP requirements.\n\nNo further products from the above list should be supplied.\u00a0 Products from alternatives suppliers are available in the majority of cases, either in equivalent strengths or varying strengths. Where there are no alternative suppliers therapeutic alternatives should be selected according to clinical practice.\n\nRemaining stocks of the affected batches should be quarantined and returned to the original supplier for credit. \u00a0For enquiries relating to stock returns please contact Wockhardt UK Ltd Customer services on 01978 669215 or email [customer.services@wockhardt.co.uk](mailto:customer.services@wockhardt.co.uk).\n\nFor medical information enquiries please contact Wockhardt UK Ltd Medical Information on 01978 661261 or email [drug.safety@wockhardt.co.uk](mailto:drug.safety@wockhardt.co.uk).\n\nMHRA is working with Wockhardt UK Ltd to ensure supply is resumed as quickly as possible; at this time there is no indication as to when new stock of these Wockhardt UK Ltd products is likely to be available.\n\nRecipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists for information.\n\nYours faithfully\n\nAdam Burgess  \nDefective Medicines Report Centre  \n151 Buckingham Palace Road  \nLondon  \nSW1W 9SZ  \nTelephone +44 (0)20 3080 6574\n\nMHRA Distribution (further recipients by cascade):  . \n\n### Download documents:  \n  \n  * [ASSET_TAG](#ASSET0)\n", 
  "raw_html": "<div class=\"inner\">          \r\n\t\t\t\t<a name=\"main\"></a>\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"title\">\r\n\t\t\t\t\t<h2>DRUG ALERT</h2>\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element14)-->\r\n\t\t\t\t\t<p>CLASS 2 MEDICINES RECALL</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element14)-->\r\n\t\t\t\t</div>\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"drugalertdetails\">\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element15)-->\r\n\t\t\t\t\t<p>Action within 48 hours</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element15)-->\r\n\t\t\t\t\t<br>\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element16)-->\r\n\t\t\t\t\t<p>Pharmacy, Clinic and Wholesaler Level Recall</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element16)-->\r\n\t\t\t\r\n\t\t\t\t\t<table id=\"dateref\">\r\n\t\t\t\t\t\t<tr>\r\n\t\t\t\t\t\t\t<td align=\"left\">\r\n\t\t\t\t\t\t\t\r\n\r\n\t\t\t\t\t\t\t17 October 2013\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<td>\r\n\t\t\t\t\t\t\tEL (13)A/24\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<td align=\"right\">\r\n\t\t\t\t\t\t\t\tOur ref:&#160;\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element17)-->\r\n\t\t\t\t\t\t\t\t MDR 56-07/13 \r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element17)-->\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t</tr>\r\n\t\t\t\t\t</table>\r\n\t\t\t\t</div>\r\n\t\t\t\t<hr>\t\t\t\t\r\n          \t\t<!--SS_BEGIN_ELEMENT(region1_element12)-->\r\n          \t\t<!--SS_END_ELEMENT(region1_element12)--> \r\n          \t\t\r\n          \t\t \r\n          \t\t\r\n          \t\t<p>Dear Healthcare Professional,</p>\r\n\r\n\t\t\t\t<div class=\"druginfo\">\r\n\t\t\t\t\t<div class=\"left\">\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t<p>\r\n\t\t\t\t\t\t\t<span>Wockhardt UK Limited</span>\r\n\t\t\t\t\t\t</p>\r\n\t\t\t\t\t\t\t\t\t\t\r\n          \t\t          \t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\t\t\t\t\t<div class=\"right\">\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t</div>\t\r\n\t\t\t\t</div>\t\t\t\t\r\n          \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment8,navigation_controls)-->\r\n\t\t\t\t<!-- only show the publication navigation controls if there is more than one page to the publication -->\r\n\t\t\t\r\n\t\t\t\t<!-- SS_END_SNIPPET(fragment8,navigation_controls)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(region1_element2,paged_publication)-->\r\n        \t\t<!-- <br>SS_DATAFILE: CON326446 -->\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<p></p><p><span>Following Drug Alert EL(13)A/19 a second Wockhardt manufacturing site in India has been inspected.&#160; The inspection identified deficiencies in good manufacturing practice (GMP) and the GMP certificate for this site has also been withdrawn.</span></p>\n\n<p><span>All unexpired stock of the below products is being recalled to pharmacy, clinic and wholesaler level, for all batches starting with the letter 'L', irrespective of pack configuration and expiry date.</span></p>\n\n<table border=\"1\" cellspacing=\"0\" cellpadding=\"0\">\n<tr>\n<td width=\"555\" valign=\"top\">\n Amiloride HCl 5mg Tablets \n</td>\n<td width=\"131\" valign=\"top\">\n PL 29831/0006 \n</td>\n</tr>\n\n<tr>\n<td width=\"555\" valign=\"top\">\n Clarithromycin 250mg Tablets \n</td>\n<td width=\"131\" valign=\"top\">\n PL 29831/0476 \n</td>\n</tr>\n\n<tr>\n<td width=\"555\" valign=\"top\">\n Clarithromycin 500mg Tablets \n</td>\n<td width=\"131\" valign=\"top\">\n PL 29831/0477 \n</td>\n</tr>\n\n<tr>\n<td width=\"555\" valign=\"top\">\n Gliclazide 80mg Tablets \n</td>\n<td width=\"131\" valign=\"top\">\n PL 29831/0103 \n</td>\n</tr>\n\n<tr>\n<td width=\"555\" valign=\"top\">\n Quinine Sulphate 300mg Tablets \n</td>\n<td width=\"131\" valign=\"top\">\n PL 29831/0182 \n</td>\n</tr>\n\n<tr>\n<td width=\"555\" valign=\"top\">\n Tamsulosin Pinexel 400mcg Capsules \n</td>\n<td width=\"131\" valign=\"top\">\n PL 29831/0366 \n</td>\n</tr>\n</table>\n\n<br>\n<p>These products have been tested on importation and Qualified Person (QP) released. There is no evidence of a risk to patient safety from products currently in the UK market; however it is considered that the products have not been manufactured in line with GMP requirements.</p>\n\n<p>No further products from the above list should be supplied.&#160; Products from alternatives suppliers are available in the majority of cases, either in equivalent strengths or varying strengths. Where there are no alternative suppliers therapeutic alternatives should be selected according to clinical practice.</p>\n\n<p>Remaining stocks of the affected batches should be quarantined and returned to the original supplier for credit. &#160;For enquiries relating to stock returns please contact Wockhardt UK Ltd Customer services on 01978 669215 or email <a href=\"mailto:customer.services@wockhardt.co.uk\">customer.services@wockhardt.co.uk</a>.</p>\n\n<p>For medical information enquiries please contact Wockhardt UK Ltd Medical Information on 01978 661261 or email <a href=\"mailto:drug.safety@wockhardt.co.uk\">drug.safety@wockhardt.co.uk</a>.</p>\n\n<p>MHRA is working with Wockhardt UK Ltd to ensure supply is resumed as quickly as possible; at this time there is no indication as to when new stock of these Wockhardt UK Ltd products is likely to be available.</p>\n\n<p>Recipients of this Drug Alert should bring it to the attention of relevant contacts by copy of this letter. Local area teams are asked to forward this to relevant clinics, general practitioners and community pharmacists for information.</p>\n\n<p align=\"left\">Yours faithfully</p>\n\n<p align=\"left\"><span>Adam Burgess<br>\nDefective Medicines Report Centre<br>\n151 Buckingham Palace Road<br>\nLondon<br>\nSW1W 9SZ<br>\nTelephone +44 (0)20 3080 6574</span></p>\r\n\r\n\t\t\t\r\n        \t\t<!-- SS_END_SNIPPET(region1_element2,paged_publication)-->\r\n        \t\t\r\n        \t\tMHRA Distribution (further recipients by cascade):\r\n        \t\t\r\n        \t\t <!--SS_BEGIN_ELEMENT(region1_element18)-->\r\n        \t\t.\r\n        \t\t<!--SS_END_ELEMENT(region1_element18)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(region1_element3,static_pdf_list)-->\r\n        \t\t<!-- the xmlListTag variable is used by the searchDocsByContentIdList include to map the name of the XML node which contains the content id -->\r\n<!--perform the search -->\r\n\t\r\n\t<!-- <br>root: Content/AssociatedContent -->\r\n\t<!-- <br>ssFragmentInstanceId: region1_element3\t -->\r\n\t<!-- <br>SS_DATAFILE: CON326446 -->\r\n\t<!-- <br>xmlListTag: ContentId\t -->\r\n\t<!-- <br>XPATH: CON326446/Content/AssociatedContent/ContentId\t -->\r\n\r\n\t<!-- xmlListTag variable should be the name of the xml node which contains a contentid.  there should be a lis of these in the XML -->\r\n\t<!-- <br>strNumRecords: 1 -->\r\n\t<!-- <br>nNumRecords: 1 -->\r\n\r\n\t\t\t<!-- using the content ID above, get the docment from conetent server-->\r\n\r\n\t\t\t\r\n\r\n\t\t<!--  dDocName <matches>`CON326447` -->\r\n\t\t\r\n<div id=\"downloadArea\">\r\n\t<h3>Download documents:</h3>\r\n\t<ul>\r\n\t\t<!-- the SearchResults will have been initialised by the call to searchDocsByContentIdList above-->\r\n\t\t\t\r\n\t\t\t\t<li>\r\n\r\n\t\t\t\t\t\t<a href=\"#ASSET0\">ASSET_TAG</a>\r\n\t\t\t\t</li>\r\n\t</ul>\r\n\t<div class=\"clearing\"><!--  --></div>\r\n\t<!--<p><a class=\"doubleArrow\" target=\"new\" href=\"http://www.adobe.com/products/acrobat/readstep2.html\">Download Acrobat Reader for free</a></p>\r\n\t<p><a class=\"doubleArrow\" target=\"new\" href=\"http://www.adobe.com/products/acrobat/access_onlinetools.html\">Adobe text conversion tools</a></p>-->\r\n</div>\r\n\t\t\t\r\n        \t\t<!-- SS_END_SNIPPET(region1_element3,static_pdf_list)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_CLOSEREGIONMARKER(region1)-->\r\n        \t\t\r\n        \t\t<!-- SS_END_CLOSEREGIONMARKER(region1)-->\r\n\t\t\t</div>\r\n\t\t", 
  "title": "Class 2 Medicines Recall (action within 48 Hours): Multiple products - Wockhardt UK Limited (EL (13)A/24)", 
  "alert_type": [
    "drugs"
  ], 
  "medical_specialism": []
}